Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
(i)
Table of Contents
Introduction1 About the Style Guide1 Section 1: Format....2
1.1 Corporate Usage/Logo.3 1.2 Headings..4 1.3 Spacing5 1.4 Margins6 1.5 Body Text7 1.5.1 Typeface7 1.5.2 Type Size...7 1.6 Bulleted and Numbered Lists...8 1.7 Headers....9 1.8 Footers.9
Section 2: Graphics10
2.1 Figures...11
Section 3: Spelling...12
3.1 Common Terms13 3.2 Initialisms..14
Section 4: Punctuation.15
4.1 Use of Commas.16 4.2 Use of Semicolons.17 4.3 Use of Colons18 4.4 Use of Dashes19 4.4.1 En Dash..19 4.4.2 Em Dash.19
(i)
5 6
7
Introduction
(i)
This document contains the local standards, process, and style information required to create Ezra user assistance documentation. The tools are intended to help professional technical communicators make document design and development decisions that save time and improve quality. User assistance documentation is part of the promise we make to clients when we provide them with a business solution from our product. Informed technical writers are key to creating and maintaining documentation in a way that presents Ezra with one face, one voice, and one high-quality user experience. Note: Ezra corporate standards and policies for client user documentation are available in the Technology section of the Company Policies and Standards page on the website (www.ezrainnovations.com).
The Standards page describes approved EZRA document types and provides links to processes, templates, and sample documents.
(i)
Section 1: Format
(i)
SYMBOL
LOGOTYPE
The Ezra Innovations signature is used to represent the organization in all its activities. This signature is the foundation to our identity and exists on a wide variety of media and marketing materials. The Ezra company logo is printed on all paper and stationary. All company documents should be printed or written on company logo stationary. The Signature consists of two elements: 1. The symbol 2. The logotype
Because the signature is a registered trademark, the relationship between these elements should never be altered. This ensures legal protect ability, builds recognition and reinforces our positioning. An electronic copy of the logo is kept secure with the IT Supervisor, George Murphy (contact number and email here).
(i)
1.2 Headings
1.3 Spacing
Spacing between all headings and the body should be double-spaced. Double-spacing should also be used in between an introduction to a list and the list. All bodies of text should be single-spaced unless specified differently by management for a particular document.
(i)
1.4 Margins
All documents should have 1.0 margins on all sides.
(i)
1.5.1 Typeface
The typeface for all body text will be Times New Roman. When numbers or text is used in a figure or illustration, then Arial will be used.
(i)
(i)
1.7 Headers
A header is used on the weekly meeting agenda. Use the following guidelines for formatting headers: Times New Roman typeface 12-point font Left alignment To read Ezra Innovations Weekly Meeting Agenda
1.8 Footers
A footer is used on proposals and agendas. Footers should also be included on any formal document sent externally from the company. The footer includes the following information: Company symbol and logotyperight alignment, 10-point font, Times New Roman typeface Page numberleft aligned, 10-point font, Times New Roman typeface DateDate the document was printed, center alignment, 10-point font, Times New Roman typeface
(i)
Section 2: Graphics
(i)
2.1 Figures
All figures used in company documentation will be provided by Michael Geranen via electronic copy. The title of the figure should be included below the figure as shown below:
Compared to
Tablet-in-Tablet
asymmetrical
symmetrical
water-insoluble polymer
water-soluble polymer
The figure settings should include: Arial Bold typeface 10-point font Drop Shadow Rectangle setting for picture effects
The title for the figure should be Arial typeface, 10-point font, left alignment. Any hotspots within the figure should use the following settings: Arial Bold typeface 9-point font
(i)
Section 3: Spelling
(i)
(i)
3.2 Initializations
ADHDAttention Deficit Hyperactivity Disorder FDAFood and Drug Administration
(i)
Section 4: Punctuation
(i)
To separate the elements in a series (three or more things), including the last two Use a comma + a little conjunction (and, but, for, nor, yet, or, so) to connect two independent clauses To set off introductory elements
o As in "Running toward third base, he suddenly realized how stupid he looked." As in "The Founders Bridge, which spans the Connecticut River, is falling down." By "parenthetical element," we mean a part of a sentence that can be removed without changing the essential meaning of that sentence. The parenthetical element is sometimes called "added information." This is the most difficult rule in punctuation because it is sometimes unclear what is "added" or "parenthetical" and what is essential to the meaning of a sentence.
To separate coordinate adjectives To set off quoted elements To set off phrases that express contrast. To avoid confusion. Typographical reasons: o Between a city and a state [Hartford, Connecticut], o a date and the year [June 15, 1997], o a name and a title when the title comes after the name [Bob Downey, Professor of English], o In long numbers [5,456,783 and $14,682], etc. Although you will often see a comma between a name and suffixBob Downey, Jr., Richard Harrison, IIIthis comma is no longer regarded as necessary by most copy editors, and some individualssuch such as Martin Luther King Jr.never used a comma there at all.
(i)
Use a semicolon in place of a period to separate two sentences where the conjunction has been left out. Use either a semicolon or a comma before introductory words such as namely, however, therefore, that is, i.e., for example, e.g., or for instance when they introduce a list following a complete sentence. Use a comma after the introductory word. Use the semicolon to separate units of a series when one or more of the units contain commas. Use the semicolon between two sentences joined by a coordinating conjunction when one or more commas appear in the first sentence.
(i)
Use the colon after a complete sentence to introduce a list of items when introductory words such as namely, for example, or that is do not appear. I want an assistant who can do the following: (1) input data, (2) write reports, and (3) complete tax forms.
A colon should not precede a list unless it follows a complete sentence; however, the colon is a style choice that some publications allow. Capitalization and punctuation are optional when using single words or phrases in bulleted form. If each bullet or numbered point is a complete sentence, capitalize the first word and end each sentence with proper ending punctuation. The rule of thumb is to be consistent. Use the colon to introduce a direct quotation that is more than three lines in length. In this situation, leave a blank line above and below the quoted material. Single space the long quotation. Some style manuals say to indent one-half inch on both the left and right margins; others say to indent only on the left margin. Quotation marks are not used. Use the colon to follow the salutation of a business letter even when addressing someone by his/her first name. Never use a semicolon after a salutation. A comma is used after the salutation for personal correspondence. Example: Dear Ms. Rodriquez:
(i)
Em Dash:
An em dash is the width of an m. Use an em dash sparingly in formal writing. In informal writing, em dashes may replace commas, semicolons, colons, and parentheses to indicate added emphasis, an interruption, or an abrupt change of thought. You are the friendthe only friendwho offered to help me.
(i)
(i)
5.1 Headings
Heading 1Arial typeface, 32-point font, Bold Heading 1 is used for the slide titles.
Heading 2Arial typeface, 24-point font, Regular Heading 2 is used for subheadings or subtitles under Heading 1 on a slide.
Heading 3Arial typeface, 20-point font, Regular Heading 3 is used for the body text on the slides.
Heading 4Arial typeface, 18-point font, Regular Heading 4 is used for text to explain tables and figures.
Heading 5Arial typeface, 14-point font, Regular Heading 5 is used for text within tables and figures.
(i)
(i)
(i)
(i)
allows the distribution surface to remain constant, allowing for a precise and controlled drug distribution over time. The benefits of this technology are the following:
Manipulate drug release rates to any desired profiles, Protect the active chemical to improve shelf life, Replicate difficult formulations found in other proprietary technologies, Non-infringing delivery system.
EZRAs drug delivery program is an engineered solution rather than a biologic approach to drug delivery systems. The tablet can be engineered to precisely control and manipulate the release of the targeted chemical compound. Through EZRAs research, they have concluded that their technology can replicate several drugs from a few of the major pharmaceutical produces, such as Johnson & Johnson and Novartis.
Project Description
EZRA relies upon the Food and Drug Administrations (FDA), expedited approval process referred to as the Abbreviated New Drug Application. Approximate development and approval time 36 months. EZRAs objectives in building value for our shareholders are the following: EZRA will help drive down the cost of medicine, The value of EZRA is in the ACT drug delivery system as a platform delivery system, Move EZRA into position to be acquired for its technology and ongoing cash flow, EZRA can compete with 80% of the sustained release drugs in the market.
The approval process is a necessity in order to show that the drug is safe. The FDA will approve a drug to be safe after it has undergone clinical testing. There are three stages to this testing: the research phase, the application process, and promising experimental drugs. The research phase is done to prepare for clinical testing in animals and humans. This phase is done to make sure that all testing is safe for animals and humans. A review board will approve the research for testing and the clinical trials begin. The results of the clinical trials are compiled into a document and submitted to the FDA with an application. Some drugs that are promising but are still undergoing investigation and testing may be used in moderately unrestricted studies for terminally ill people that dont have a choice. But these expanded access protocols still require clinical researchers to formally investigate the drug in well-controlled studies and to supply some evidence that the drug is likely to be helpful. The FDA will approve a drug if the results prove to be effective to the users and if the product is safe. This process usually takes three to five years.
Project Revenue
Year 1 Year 2 Year 3
(i)
Year 4
Year 5
Year 6
Drug 1 Revenue Drug 2 Revenue Total Drug Revenue Interest Income UAMS Royalty Developer Royalty Gross Profit
X,XXX,XXX
(i)
Meeting: Internal Weekly Status Meeting Date Time Location 12:00 p.m. 1:00 p.m. central N/A
(i)
Teleconference Purpose Facilitator Invitees: Joe Fix Brett Matthews Dr. Kim Michael Douglas
Meeting Agenda Item Roll call of Attendees Administrative Items - Time Entry - Vacation Time - Open Overall Project Status Review StatusProduct Development - Late Tasks (Small Late Tab) - Upcoming Status - General Status - Open Review StatusFinancial - Budget - Goal for project - Miscellaneous - Open Business Analysis - Upcoming Meetings - Clients/Investors - Deliverable to UAMS Production - Timeframe - Tasks in progress General Discussion
Michael/Joe
10 mins
Brett
5 mins
Michael
5 mins
Michael/Joe Team
(i)
5 mins 5 mins
Current Vacation Schedule: November Brett Matthews: 26-Nov Michael Geranen: 18 22 Nov December Next Meeting Tuesday, November 8th Action Items Description Need to Develop Calendar for Code, SIT, etc. Recommend leveraging Darlas current calendar Completed: The SharePoint calendar currently in use for Sales & Service can be used for Testing, per Shari.
No. 14
Assigned To S. Ivie
(i)
(i)